Virtual Ward Rounds in Heart Failure: Personalising Management Across the EF Spectrum
Published: 18 January 2022
-
Views:
56922
-
Likes:
7
-
Views:
56922
-
Likes:
7
-
21m 24sPart 1 | Session 1 Ejection Fraction - How Important Is It Today? Martin R Cowie, Richard Hobbs, Bharathi Upadhya , Kieran Docherty
-
19m 49sPart 1 | Session 2 HFrEF and HFpEF Case Review Martin R Cowie, Richard Hobbs, Bharathi Upadhya , Kieran Docherty
-
15m 54sPart 1 | Session 3 The Expanding Role of Primary Care in Ongoing HF Management Martin R Cowie, Richard Hobbs, Bharathi Upadhya , Kieran Docherty
-
6m 52sPart 2 | Session 1 Patient Profile 1: Follow up Kieran Docherty
-
9m 21sPart 2 | Session 2 Patient Profile 2: Follow up Bharathi Upadhya
-
9m 6sPart 2 | Session 3 Management De-brief of a Complex Case - Barriers in the Management of HFrEF Kieran Docherty
-
6m 54sPart 3 | Session 1 Patient Profile 1: Presented by Dr Kieran Docherty Kieran Docherty
-
8m 22sPart 3 | Session 2 Patient Profile 2: Presented by Dr Bharathi Upadhya Bharathi Upadhya
Overview
Watch this programme seeking to educate physicians in the changing landscape of the medical management of heart failure.
In the main event, Prof Martin Cowie (Royal Brompton Hospital, UK) chairs a roundtable discussion, and is joined by Dr Kieran Docherty (University of Glasgow, UK), Dr Bharathi Upadhya (Atrium Health Wake Forest Baptist, US) and Prof Richard Hobbs (University of Oxford, UK). During this roundtable, our expert panel discuss two patient cases and their treatment strategies based on recent guidelines and data updates. The panel also analyse survey data, discuss the importance of EF, and the role of primary care in ongoing heart failure management.
The final part explores how each of the patients has responded and how their quality of life and functional capacity has changed as a result. Dr Docherty also discusses the main challenges that he experienced during the management of his patient, and shares his advice on how complex patients like these can be treated.
Key Learning Objectives
Upon participation in this programme physicians should be able to:
- Apply results from real world and randomised controlled clinical trial data to surrogate, virtual patients
- Identify different HF phenotypes based on EF, patient age, sex and comorbidities
- Stratify stabilised HFpEF patients to an appropriate management approach according to patient characteristics
- Discuss the merits of using EF and other patient characteristics to guide treatment
Target Audience
- General Cardiologists
- Heart Failure Specialists
- Primary Care Physicians
- Allied Healthcare Professionals
- Nephrologists
More from this programme
Part 1
Roundtable Discussion
Part 2
Patient Follow Up
Part 3
Patient Case Presentations
Faculty Biographies
Martin R Cowie
Professor of Cardiology
Martin Cowie is Professor of Cardiology at King's College London, and Honorary Consultant Cardiologist at the Royal Brompton Hospital, London, UK. Prof Cowie chairs the Clinical Practice Committee of the British Cardiac Society and sits on the UK Department of Health’s Primary Care and Heart Failure Implementation Board.
Prof Cowie's research interests focus on health technology assessment and delivery of efficient and effective care for patients with heart failure, with a focus on diagnostics, drugs, and devices. He has had a longstanding interest in evaluating remote monitoring and other digital technologies in heart failure.
Prof Cowie’s studies and reviews have been published in a variety of peer-reviewed journals, including The Lancet, European Heart Journal, British Medical Journal, Heart and International Journal of Cardiology. He is a member of the editorial boards of Heart, The British Journal of Diabetes and…
Richard Hobbs
Professor and Head of Primary Care Health Services
Richard Hobbs is Professor and Head of Primary Care Health Sciences at the University of Oxford, UK. He is Co-Director of the Quality and Outcomes Review Panel and Deputy Director of the National Institute for Health Research National School for Primary Care Research.
Professor Hobbs serves on numerous scientific boards and is chair of the European Society of Cardiology (ESC) Council of Primary Care, as well as the Prevention and Care Board of the British Heart Foundation (BHF). His publications include 25 book chapters, nine edited books and more than 250 original papers in peer-reviewed journals.
Kieran Docherty
Clinical Lecturer (Institute of Cardiovascular & Medical Sciences)
Kieran Docherty studied medicine at the University of Glasgow from 2005-2011. He is a Cardiology Specialist Registrar in the West of Scotland Deanery and a Clinical Research Fellow at the Institute of Cardiovascular and Medical Sciences at the University of Glasgow. He is undertaking a PhD examining the effects of neprilysin inhibition on left ventricular remodelling.
Bharathi Upadhya
Associate Professor/Cardiovascular Medicine
Dr Bharathi Upadhya is a clinician investigator with a board certification in Cardiovascular Medicine, Echocardiography, Nuclear Cardiology and Adult Congenital Heart Disease.
Her research spans a wide range of topics in cardiovascular medicine including medical imaging-related projects and cardiac rehabilitation, exercise physiology, and aging. However, her most intense focus has been heart failure, particularly heart failure with preserved ejection fraction (HFpEF).